Authors: NEIDHART W BREU V BURRI K CLOZEL M HIRTH G KLINKHAMMER U GILLER T RAMUZ H

Citation: W. Neidhart et al., DISCOVERY OF RO-48-5695 - A POTENT MIXED ENDOTHELIN RECEPTOR ANTAGONIST OPTIMIZED FROM BOSENTAN, Bioorganic & medicinal chemistry letters, 7(17), 1997, pp. 2223-2228

Authors: BREU V CLOZEL M BURRI K HIRTH G NEIDHART W RAMUZ H

Citation: V. Breu et al., IN-VITRO CHARACTERIZATION OF RO-46-8443, THE FIRST NONPEPTIDE ANTAGONIST SELECTIVE FOR THE ENDOTHELIN ET(B) RECEPTOR, FEBS letters, 383(1-2), 1996, pp. 37-41

Authors: NEIDHART W BREN V BUR D BURRI K CLOZEL M HIRTH G MULLER M WESSEL HP RAMUZ H

Citation: W. Neidhart et al., THE DISCOVERY OF NONPEPTIDE ENDOTHELIN RECEPTOR ANTAGONISTS - PROGRESSION TOWARDS BOSENTAN, Chimia, 50(11), 1996, pp. 519-524

Authors: CLOZEL M BREU V GRAY GA KALINA B LOFFLER BM BURRI K CASSAL JM HIRTH G MULLER M NEIDHART W RAMUZ H

Citation: M. Clozel et al., PHARMACOLOGICAL CHARACTERIZATION OF BOSENTAN, A NEW POTENT ORALLY-ACTIVE NONPEPTIDE ENDOTHELIN RECEPTOR ANTAGONIST, The Journal of pharmacology and experimental therapeutics, 270(1), 1994, pp. 228-235

Authors: CLOZEL M BREU V BURRI K CASSAL JM FISCHLI W GRAY GA HIRTH G LOFFLER BM MULLER M NEIDHART W RAMUZ H

Citation: M. Clozel et al., PATHOPHYSIOLOGICAL ROLE OF ENDOTHELIN REVEALED BY THE 1ST ORALLY-ACTIVE ENDOTHELIN RECEPTOR ANTAGONIST, Nature, 365(6448), 1993, pp. 759-761